3OUH
PHD2-R127 with JNJ41536014
Summary for 3OUH
Entry DOI | 10.2210/pdb3ouh/pdb |
Related | 3OUI 3OUJ |
Descriptor | Egl nine homolog 1, FE (II) ION, SULFATE ION, ... (5 entities in total) |
Functional Keywords | phd2, oxidoreductase |
Biological source | Homo sapiens (human) |
Cellular location | Cytoplasm : Q9GZT9 |
Total number of polymer chains | 1 |
Total formula weight | 27011.83 |
Authors | |
Primary citation | Rosen, M.D.,Venkatesan, H.,Peltier, H.M.,Bembenek, S.D.,Kanelakis, K.C.,Zhao, L.X.,Leonard, B.E.,Hocutt, F.M.,Wu, X.,Palomino, H.L.,Brondstetter, T.I.,Haugh, P.V.,Cagnon, L.,Yan, W.,Liotta, L.A.,Young, A.,Mirzadegan, T.,Shankley, N.P.,Barrett, T.D.,Rabinowitz, M.H. Benzimidazole-2-pyrazole HIF Prolyl 4-Hydroxylase Inhibitors as Oral Erythropoietin Secretagogues. ACS Med Chem Lett, 1:526-529, 2010 Cited by PubMed Abstract: HIF prolyl 4-hydroxylases (PHD) are a family of enzymes that mediate key physiological responses to hypoxia by modulating the levels of hypoxia inducible factor 1-α (HIF1α). Certain benzimidazole-2-pyrazole carboxylates were discovered to be PHD2 inhibitors using ligand- and structure-based methods and found to be potent, orally efficacious stimulators of erythropoietin secretion in vivo. PubMed: 24900242DOI: 10.1021/ml100198y PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.51 Å) |
Structure validation
Download full validation report